Lumos Pharma(LUMO) - 2020 Q3 - Quarterly Report
Lumos PharmaLumos Pharma(US:LUMO)2020-11-12 19:57
Transcript
Slide

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. For the quarterly period ended September 30, 2020. ☐ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. For the transition period from to . Commission File Number 001-35342 Delaware 42-1491350 4200 Marathon Blvd #200 Austin, Texas 78756 (512) 215-2630 (Address, including zip code, ...